Hims & Hers has risen since November 2024, outperforming the S&P 500. Click here to see why HIMS stock is a Buy.
2d
Zacks Investment Research on MSNNew Thrombectomy Product Launches Support PEN Stock Amid Macro IssuesPenumbra PEN is gaining traction in the U.S. and international markets on strong customer uptake of its Lightning Bolt and Flash lines. Yet, unfavorable currency movements and rising expenses are ...
SHOPPING: Give yourself the gift of improved sense of self with the once-a-day treatment that contains ingredients to support ...
Since 2006, Chang Gung Memorial Hospital has pioneered the use of the Da Vinci Robotic Surgical Systems. By the end of 2024, ...
Learn more about whether Alignment Healthcare, Inc. or Hims & Hers Health, Inc. is a better investment based on AAII's A+ ...
Learn more about whether Hims & Hers Health, Inc. or LifeStance Health Group, Inc. is a better investment based on AAII's A+ ...
Cube will underpin many of the AI tools we will develop in the years to come, including highly complex scene-generation tools ...
6d
Zacks Investment Research on MSNNew Product Launches to Support HOLX Stock Amid Macro IssuesHologic HOLX has been gaining from new strategic product launches across Diagnostics and Breast Health. However, ...
Hims & Hers is shifting towards personalized medicine with AI-backed solutions. Find out why HIMS stock is buyable despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results